January 30, 2019
Immunogenicity and Safety Study of 1 and 2 Doses of GlaxoSmithKline (GSK) Biologicals’ Meningococcal Vaccine MenACWY-TT (GSK134612) in Toddlers, Persistence up to 5 Years After Vaccination and Co-administration With Pfizer’s Prevenar 13™Vaccine
Read More
December 10, 2018
A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
Read More
X